From: An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study
Experienced an adverse event
Randomised Group
Intervention
Standard
Total
No
23
20
43
Yes
4 (14.8%)
5 (20.0%)
9
27
25
52